EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer.
暂无分享,去创建一个
W. Scheithauer | H. Lenz | A. Zubel | H. Burris | L. Fehrenbacher | C. Borg | J. Maurel | C. Langer | G. Middleton | M. Lutz | G. Luppi | C. Eng | A. Sobrero | J. Prausová | H. Burris | O. Kisker | H. Kröning | M. E. Vega-Villegas | Y. Abubakr | J. Kopit | E. U. Steinhauer | E. Steinhauer